Bio-Connect
Product image
Product image
Product image

InVivoPlus anti-mouse CD8alpha

Research Use Only
BP0004-1
Bio X Cell
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, Other Application
Product group Antibodies
ReactivityMouse
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoPlus anti-mouse CD8alpha
  • Delivery Days Customer
    7
  • Applications
    Flow Cytometry, ImmunoFluorescence, Western Blot, Other Application
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    53-6.7
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Rat
  • Isotype
    IgG2a
  • Reactivity
    Mouse
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Wang W et al., 2018 Nov 12, Cancer Cell
    Read more
  • MET is required for the recruitment of anti-tumoural neutrophils. Finisguerra V et al., 2015 Jun 18, Nature
    Read more
  • Suppression of Fcgamma-receptor-mediated antibody effector function during persistent viral infection. Yamada DH et al., 2015 Feb 17, Immunity
    Read more
  • Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells. Christensen AD et al., 2015 Mar, Clin Exp Immunol
    Read more
  • Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy. Walsh KB et al., 2014 Jun, J Virol
    Read more
  • TNF-alpha-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanoma. Uddin MN et al., 2014 Feb 15, J Immunol
    Read more
  • Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection. Cyktor JC et al., 2013, PLoS One
    Read more
  • The immunocytokine L19-IL2 eradicates cancer when used in combination with CTLA-4 blockade or with L19-TNF. Schwager K et al., 2013 Mar, J Invest Dermatol
    Read more
  • Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth. Hervieu A et al., 2013 Feb, J Invest Dermatol
    Read more
  • The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. Hafalla JC et al., 2012 Feb, PLoS Pathog
    Read more

Related products

Product image
Product group Antibodies
References
Bio X Cell
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, Other Application
ReactivityMouse
  • SizePrice
Product image
Product group Antibodies
References
Bio X Cell
  • SizePrice
Product image
Product group Chemicals
Bio X Cell
  • SizePrice
Product image
Product group Antibodies
References
Bio X Cell
ApplicationsOther Application
ReactivityHuman
  • SizePrice
Product image
Product group Antibodies
References
Bio X Cell
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, Other Application
ReactivityMouse
  • SizePrice
Product image
Product group Antibodies
References
Bio X Cell
ApplicationsFlow Cytometry, Western Blot, Other Application
ReactivityMouse
  • SizePrice
Product image
Product group Antibodies
References
Bio X Cell
ApplicationsNeutralisation/Blocking
ReactivityMouse
  • SizePrice
Product image
Product group Antibodies
References
Bio X Cell
ApplicationsNeutralisation/Blocking, Other Application
ReactivityMouse
  • SizePrice
Product image
Product group Antibodies
References
Bio X Cell
ApplicationsWestern Blot, Neutralisation/Blocking
ReactivityMouse
  • SizePrice
Product image
Product group Antibodies
References
Bio X Cell
ApplicationsFlow Cytometry, Neutralisation/Blocking
ReactivityHuman
  • SizePrice